PCOS isn’t a single condition with one presentation. It shows up differently depending on which combination of symptoms you have, and understanding your specific pattern can shape how you and your doctor approach management. The most widely used classification system identifies four distinct phenotypes based on three core features: excess androgens (male-pattern hormones), irregular or absent ovulation, and polycystic-appearing ovaries on imaging.
Beyond those official phenotypes, you’ll also encounter informal categories like “insulin-resistant PCOS” or “inflammatory PCOS” that describe the underlying driver rather than the symptom combination. Both frameworks are useful, and they overlap more than they compete.
The Four Rotterdam Phenotypes
Since 2003, the Rotterdam criteria have been the international standard for diagnosing PCOS. A diagnosis requires at least two of three features: excess androgens, ovulatory dysfunction (irregular or missing periods), and polycystic ovaries on ultrasound. The 2023 international guideline update kept these criteria in place while adding that a blood marker called AMH can now substitute for ultrasound in adults.
The four phenotypes break down like this:
- Phenotype A (full-blown or classic): All three features present. Excess androgens, irregular ovulation, and polycystic ovaries. This is the most metabolically severe form and accounts for roughly 24% of Rotterdam-diagnosed cases in community studies.
- Phenotype B (classic without polycystic ovaries): Excess androgens plus ovulatory dysfunction, but ovaries appear normal on imaging. This is actually the most common phenotype, representing about 46% of cases in one large population study.
- Phenotype C (ovulatory): Excess androgens plus polycystic ovaries, but cycles are relatively regular. About 22% of cases. Because periods seem normal, this type often goes undiagnosed longer.
- Phenotype D (non-hyperandrogenic): Ovulatory dysfunction plus polycystic ovaries, but no clinical or lab evidence of excess androgens. This is the mildest and least common form at around 8% of cases. Some researchers have debated whether it should be classified as PCOS at all.
Phenotypes A and B tend to carry the highest risk for metabolic complications like insulin resistance and abnormal cholesterol. Phenotype D, without the androgen excess, generally carries the lowest metabolic risk. Knowing your phenotype gives your doctor a clearer picture of what to monitor over time.
Insulin-Resistant PCOS
Insulin resistance is the single most common underlying driver. Somewhere between 35% and 80% of people with PCOS have it, with the wide range depending on body weight and how it’s measured. It’s especially prevalent in those who also carry extra weight, but it can occur at any size.
Here’s the mechanism: when your cells stop responding efficiently to insulin, your pancreas pumps out more to compensate. That extra insulin doesn’t just affect blood sugar. It acts directly on the ovaries, amplifying the signal that tells them to produce androgens. So hyperinsulinemia isn’t just a side effect of PCOS. It’s one of the forces actively driving it. Higher androgens then disrupt ovulation, which leads to irregular periods and difficulty conceiving.
Signs that insulin resistance may be your primary driver include skin darkening in creases (neck, armpits, groin), strong sugar cravings, difficulty losing weight despite effort, and fatigue after meals. A fasting insulin test or a two-hour oral glucose tolerance test can help confirm it. Major medical organizations recommend glucose tolerance testing for everyone with PCOS regardless of body size, since insulin problems can develop well before weight gain becomes obvious.
Adrenal PCOS
In most people with PCOS, the ovaries are the main source of excess androgens. But more than 50% of those with PCOS also have elevated androgen production from the adrenal glands. When the adrenals are the primary driver and ovarian androgens are relatively normal, some clinicians refer to this as adrenal PCOS.
The key marker is DHEAS, a hormone produced almost exclusively by the adrenal glands. In classic ovarian-driven PCOS, DHEAS is normal or only slightly elevated, while testosterone tends to be high. In adrenal-driven cases, the pattern flips: DHEAS is notably elevated while testosterone may be closer to normal. Interestingly, lean PCOS patients tend to have higher DHEAS levels than those with higher body weight, which may partly explain why adrenal PCOS is more commonly discussed in the context of normal-weight individuals.
One important distinction: if androgenic symptoms develop rapidly (severe acne, hair growth, or voice changes appearing over weeks rather than months), and DHEAS levels are very high (above 700 ng/mL), that pattern points away from PCOS entirely and toward an adrenal tumor that needs urgent evaluation. The gradual onset of symptoms is what typically distinguishes PCOS from more serious adrenal conditions.
Inflammatory PCOS
Chronic low-grade inflammation plays a role in many PCOS cases, but for some people it appears to be the central feature. People with PCOS are more likely to have elevated C-reactive protein (CRP), a blood marker that signals ongoing inflammation in the body. They also tend to show higher levels of inflammatory immune signals and elevated white blood cell counts.
Inflammatory PCOS is often suspected when you have PCOS symptoms alongside signs of systemic inflammation: joint pain, unexplained fatigue, skin issues like eczema or persistent redness, headaches, or digestive problems. The inflammation itself can stimulate the ovaries to produce excess androgens, creating a cycle where inflammation drives hormonal disruption and hormonal disruption feeds more inflammation.
Common triggers include dietary sensitivities (particularly gluten and dairy for some individuals), gut imbalances, environmental toxin exposure, and chronic stress. A CRP blood test is one of the simplest ways to check for this pattern. Unlike insulin-resistant PCOS, where the metabolic picture is usually the clearest clue, inflammatory PCOS often shows up with a broader constellation of whole-body symptoms beyond the reproductive system.
Post-Pill PCOS
This is the most controversial “type” because, strictly speaking, stopping hormonal birth control cannot cause PCOS. What it can do is unmask symptoms that were being suppressed by the pill, or trigger a temporary hormonal disruption that looks a lot like PCOS.
Hormonal contraceptives lower androgen levels. When you stop taking them, your body’s androgen production may temporarily surge as it recalibrates. That can cause acne flares, hair thinning, oily skin, and irregular periods that check several PCOS boxes. Your natural menstrual cycle may take about three months to return to its typical pattern.
The distinguishing feature of post-pill PCOS is that it resolves on its own. If you didn’t have PCOS before starting birth control, symptoms from stopping should ease within a few months. If symptoms persist beyond that window, it’s more likely that the pill was masking true PCOS that was already developing. This is why many clinicians recommend waiting at least three to six months after stopping contraception before pursuing a formal PCOS diagnosis.
Lean PCOS
PCOS is commonly associated with higher body weight, but a significant subset of people with the condition have a normal or low BMI. Lean PCOS has a distinct hormonal and metabolic fingerprint compared to PCOS in higher-weight individuals.
On the metabolic side, people with lean PCOS tend to have lower blood pressure, lower LDL cholesterol, lower triglycerides, and lower fasting blood sugar. Their insulin resistance scores are also lower, though not necessarily normal. This more favorable metabolic profile is one reason lean PCOS frequently goes undiagnosed: without the visible weight gain that prompts testing, doctors may not think to check.
Hormonally, lean PCOS shows a different pattern. The ratio of LH to FSH (two hormones that regulate the menstrual cycle) tends to be higher in lean individuals, which is often what drives the ovulatory dysfunction. DHEAS levels are also higher, suggesting more adrenal involvement. On the other hand, free testosterone tends to be lower than in higher-weight PCOS, meaning some of the classic androgenic symptoms like severe hirsutism may be milder. AMH levels and androstenedione don’t differ significantly between the two groups.
How Your Type Gets Identified
There’s no single test that sorts you neatly into one category. Diagnosis starts with the same basic workup: a clinical assessment for androgenic signs (excess acne, male-pattern hair growth, hair thinning), a menstrual history, and either an ultrasound or AMH blood test to evaluate ovarian morphology. Those three pieces determine your Rotterdam phenotype.
To identify the underlying driver, additional bloodwork fills in the picture. Total and free testosterone levels point to ovarian androgen excess. DHEAS levels reveal adrenal contribution. Fasting insulin or a glucose tolerance test evaluates insulin resistance. CRP can flag chronic inflammation. A lipid panel and blood pressure check assess cardiovascular risk. A progesterone measurement called 17-OH progesterone helps rule out an adrenal condition called non-classic congenital adrenal hyperplasia, which can mimic PCOS closely.
Most people with PCOS don’t fit perfectly into one informal category. You might have insulin resistance as your primary driver with a significant inflammatory component, or adrenal androgen excess alongside mild insulin resistance. The categories are useful as a starting framework for understanding what’s happening in your body, not as rigid boxes. What matters most is identifying which mechanisms are most active in your case, because that determines which management strategies are likely to make the biggest difference.